BREAKING NEWS

U.S. health regulator approves Teva's migraine drug

By REUTERS

SEPTEMBER 15, 2018 01:29

Israeli drugmaker Teva Pharmaceutical Industries on Friday received approval from the U.S. Food and Drug Administration to sell its new migraine treatment, a key drug the company has been banking on to help revive its fortunes.

The world's largest generic drugmaker had hoped to receive approval for the injectable drug, fremanezumab, by June. Its release was delayed due to U.S. regulatory concerns about the manufacturing process at the South Korean plant of its development partner Celltrion.

Around 39 million Americans suffer from migraine headaches, according to the Migraine Research Foundation, making for a large market that has attracted several drugmakers.

Trump: Kamala will start WW3, get millions of Muslims killed

By JERUSALEM POST STAFF

11/05/2024 01:10 PM

Putin tells Western diplomats Russia is committed to cooperation

By REUTERS

11/05/2024 01:08 PM

Germany says Iran is responsible for death of Sharmahd

By REUTERS

11/05/2024 12:33 PM

Iranian female student who stripped in public is 'troubled'

By REUTERS

11/05/2024 12:31 PM